Anumana’s joins ACC to advance AI solutions for detecting heart failure

Building on our previous discussion of imbalanced regression, we now turn to another critical challenge: uncertainty estimation. While addressing data imbalance helps models pay attention to rare cases, we must also…

MarketScreener: Anumana, Inc. announced that it has received a round of funding from new investor, Boston Scientific Corporation on April 24, 2025. The transaction included participation from returning investors, Matrix…

Company to highlight how its ECG-AI® algorithms enable earlier cardiovascular disease detection